These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

316 related articles for article (PubMed ID: 18971448)

  • 1. Comorbidity delays diagnosis and increases disability at diagnosis in MS.
    Marrie RA; Horwitz R; Cutter G; Tyry T; Campagnolo D; Vollmer T
    Neurology; 2009 Jan; 72(2):117-24. PubMed ID: 18971448
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Changes in the ascertainment of multiple sclerosis.
    Marrie RA; Cutter G; Tyry T; Hadjimichael O; Campagnolo D; Vollmer T
    Neurology; 2005 Oct; 65(7):1066-70. PubMed ID: 16217060
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Association between comorbidity and clinical characteristics of MS.
    Marrie RA; Horwitz RI; Cutter G; Tyry T; Vollmer T
    Acta Neurol Scand; 2011 Aug; 124(2):135-41. PubMed ID: 20880264
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Vascular comorbidity is associated with more rapid disability progression in multiple sclerosis.
    Marrie RA; Rudick R; Horwitz R; Cutter G; Tyry T; Campagnolo D; Vollmer T
    Neurology; 2010 Mar; 74(13):1041-7. PubMed ID: 20350978
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Vascular comorbidities in multiple sclerosis: a nationwide study from Denmark.
    Thormann A; Magyari M; Koch-Henriksen N; Laursen B; Sørensen PS
    J Neurol; 2016 Dec; 263(12):2484-2493. PubMed ID: 27699465
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Frequency of Comorbidities and Their Association with Clinical Disability and Relapse in Multiple Sclerosis.
    Tettey P; Siejka D; Simpson S; Taylor B; Blizzard L; Ponsonby AL; Dwyer T; van der Mei I
    Neuroepidemiology; 2016; 46(2):106-13. PubMed ID: 26784322
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Comorbidity in multiple sclerosis is associated with diagnostic delays and increased mortality.
    Thormann A; Sørensen PS; Koch-Henriksen N; Laursen B; Magyari M
    Neurology; 2017 Oct; 89(16):1668-1675. PubMed ID: 28931645
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Substantial adverse association of visual and vascular comorbidities on visual disability in multiple sclerosis.
    Marrie RA; Cutter G; Tyry T
    Mult Scler; 2011 Dec; 17(12):1464-71. PubMed ID: 21844067
    [TBL] [Abstract][Full Text] [Related]  

  • 9. High frequency of adverse health behaviors in multiple sclerosis.
    Marrie R; Horwitz R; Cutter G; Tyry T; Campagnolo D; Vollmer T
    Mult Scler; 2009 Jan; 15(1):105-13. PubMed ID: 18845651
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Factors associated with delay to medical recognition in two Canadian multiple sclerosis cohorts.
    Kingwell E; Leung AL; Roger E; Duquette P; Rieckmann P; Tremlett H;
    J Neurol Sci; 2010 May; 292(1-2):57-62. PubMed ID: 20202651
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Measures of general and abdominal obesity and disability severity in a large population of people with multiple sclerosis.
    Fitzgerald KC; Salter A; Tyry T; Fox RJ; Cutter G; Marrie RA
    Mult Scler; 2020 Jul; 26(8):976-986. PubMed ID: 31079537
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The burden of mental comorbidity in multiple sclerosis: frequent, underdiagnosed, and undertreated.
    Marrie RA; Horwitz R; Cutter G; Tyry T; Campagnolo D; Vollmer T
    Mult Scler; 2009 Mar; 15(3):385-92. PubMed ID: 19153176
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Psychiatric comorbidity is associated with disability progression in multiple sclerosis.
    McKay KA; Tremlett H; Fisk JD; Zhang T; Patten SB; Kastrukoff L; Campbell T; Marrie RA;
    Neurology; 2018 Apr; 90(15):e1316-e1323. PubMed ID: 29523642
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Comorbidity, socioeconomic status and multiple sclerosis.
    Marrie R; Horwitz R; Cutter G; Tyry T; Campagnolo D; Vollmer T
    Mult Scler; 2008 Sep; 14(8):1091-8. PubMed ID: 18728060
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Delayed diagnosis of multiple sclerosis in a low prevalence country.
    Cárdenas-Robledo S; Lopez-Reyes L; Arenas-Vargas LE; Carvajal-Parra MS; Guío-Sánchez C
    Neurol Res; 2021 Jul; 43(7):521-527. PubMed ID: 33357115
    [No Abstract]   [Full Text] [Related]  

  • 16. Emerging effects of comorbidities on multiple sclerosis.
    Marrie RA; Horwitz RI
    Lancet Neurol; 2010 Aug; 9(8):820-8. PubMed ID: 20650403
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Disability status, disease parameters, defense styles, and ego strength associated with psychiatric complications of multiple sclerosis.
    Hyphantis TN; Christou K; Kontoudaki S; Mantas C; Papamichael G; Goulia P; Konitsiotis S; Mavreas V
    Int J Psychiatry Med; 2008; 38(3):307-27. PubMed ID: 19069575
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Factors associated with perceived need for mental health care in multiple sclerosis.
    Orr J; Bernstein CN; Graff LA; Patten SB; Bolton JM; Sareen J; Marriott JJ; Fisk JD; Marrie RA;
    Mult Scler Relat Disord; 2018 Oct; 25():179-185. PubMed ID: 30096684
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prevalence of comorbidities in Multiple Sclerosis and impact on physical disability according to disease phenotypes.
    Ciampi E; Uribe-San-Martin R; Soler B; Molnar K; Reyes D; Keller K; Carcamo C
    Mult Scler Relat Disord; 2020 Nov; 46():102565. PubMed ID: 33039942
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The impact of sexual dysfunction on health-related quality of life in people with multiple sclerosis.
    Schairer LC; Foley FW; Zemon V; Tyry T; Campagnolo D; Marrie RA; Gromisch ES; Schairer D
    Mult Scler; 2014 Apr; 20(5):610-6. PubMed ID: 23999609
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.